TransMedics Gr (NASDAQ:TMDX) reported quarterly earnings of $0.30 per share which missed the analyst consensus estimate of $0.61 by 50.82 percent. This is a 59.46 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $173.933 million which beat the analyst consensus estimate of $172.636 million by 0.75 percent. This is a 21.18 percent increase over sales of $143.537 million the same period last year.